Alpha memo: skeletal muscle resveratrol exercise cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The one-sentence alpha could more explicitly state the cross-species directionality (rodent augmentation vs. human null) for quicker scanning.
• Receipt 1's title in the bundle says 'Improvements in skeletal muscle strength and cardiac function' but the memo frames it as 'skeletal-muscle, cardiac, or inflammatory endpoints' — acceptable since the source covers cardiac endpoints, though inflammatory endpoints are not a Receipt 1 focus and are only present in Receipt 2.

Reviewer note

Bounded alpha-memo with a clear, single research signal: rodent models show resveratrol + exercise augmentation, while the one cited human RCT in aged men shows a null additive effect on skeletal-muscle mitochondrial and inflammatory endpoints. The two-receipt bundle directly supports the stated cross-context heterogeneity. Exact statistics (fold-changes, dose, duration, population age) match the source excerpts closely. Limitations are explicit and material: species, dose, duration, endpoint, and population differences are enumerated, and a concrete falsifier is specified. Title/source alignment is clean — both receipts concern resveratrol co-treatment with exercise in skeletal muscle. No clinical, policy, or investment claims are made; the memo explicitly declines supplementation or dosing recommendations. Gaps and next-step falsifier are specific and actionable. Accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis